CD84 as a therapeutic target for breaking immune tolerance in triple-negative breast cancer.
Rabani S, Gunes EG, Gunes M, Pellegrino B, Lampert B, David K, Pillai R, Li A, Becker-Herman S, Rosen ST, Shachar I.
Rabani S, et al. Among authors: pillai r.
Cell Rep. 2024 Nov 26;43(11):114920. doi: 10.1016/j.celrep.2024.114920. Epub 2024 Oct 28.
Cell Rep. 2024.
PMID: 39466774
Free article.